ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer represents one of the most formidable subtypes of breast malignancies, characterized by its marked biological diversity, rapid proliferation, early metastatic spread, and the absence of actionable hormonal or HER2 targets [2, 3].